Gilead Sciences
GILD
#127
Rank
C$212.83 B
Marketcap
C$171.53
Share price
2.32%
Change (1 day)
30.85%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): C$9.14

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$9.00. In 2024 the company made an earnings per share (EPS) of C$0.52 a decrease over its 2023 EPS that were of C$6.28.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.141642.56%
2024C$0.52-91.65%
2023C$6.2823.98%
2022C$5.06-25.86%
2021C$6.834850%
2020C$0.14-97.64%
2019C$5.850.9%
2018C$5.8018.71%
2017C$4.89-64.88%
2016C$13.91-18.45%
2015C$17.0655.28%
2014C$10.99296.02%
2013C$2.7717.89%
2012C$2.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
C$17.98 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$19.78 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$1.87-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$6.17-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.17 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.37-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$14.41 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$28.32 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.48 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA